Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




AstraZeneca Pushes for U.S. Reviews of TV Drug Ads
Link ID 5236
Title AstraZeneca Pushes for U.S. Reviews of TV Drug Ads
Url http://www.medscape.com/viewarticle/573524?src=rss
Description AstraZeneca Plc is urging U.S. lawmakers to revive a program for drugmakers who want to voluntarily submit their television commercials for regulatory review, according to a letter provided to Reuters. Reuters Health Information
Category Articles > Business of Medicine
Keywords
Date Apr 29, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. What are the Benefits and Risks of Fitting Patients With Radiofrequency Identification Devices
  Radiofrequency identification devices: what are they? How are they used? What are their advantages related to healthcare? What are the potential unintended risks and ethical concerns for patients?
PLoS Medicine
Category:   Articles > Business of Medicine


2. U.S. Approves UnitedHealth Buying Sierra Health
  Insurer UnitedHealth Group Inc won U.S. antitrust approval on Monday to buy Sierra Health Services Inc, despite criticism of the deal. Reuters Health Information
Category:   Articles > Business of Medicine


3. WellPoint Probing Data Breach for 130,000 Members
  Health insurer WellPoint Inc is investigating the cause of a breach involving protected health information for about 130,000 members, the company said on Wednesday. Reuters Health Information
Category:   Articles > Business of Medicine


4. U.S. Unveils Plan for Drug, Device Safety Tracking
  U.S. health officials on Thursday announced plans for a new computer tracking system designed to help officials identify dangers from prescription drugs and medical devices after they reach the market. Reuters Health Information
Category:   Articles > Business of Medicine


5. Bolder FDA Warnings for Amgen, J&J Anemia Drugs
  Warning labels on anemia drugs made by Amgen Inc and Johnson & Johnson have been strengthened to reflect concerns the drugs boost risk of heart attacks, stroke and death, regulators said on Thursday. Reuters Health Information
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS